Brice de Kinkelin

Brice de Kinkelin is a highly accomplished professional in the pharmaceutical industry, currently serving as the Key Account Manager for Haematology (CLL) at AstraZeneca in Switzerland.1 His career is characterized by a strong background in pharmaceutical sales, marketing, and rare disease management.

Education and Expertise

Brice holds an impressive educational background, including:

• Master of Business Administration (MBA)
• Master of Science in Management with a specialization in Marketing
• MBA in Digital Marketing and Business1

This diverse academic foundation has equipped him with a comprehensive understanding of business strategies, marketing principles, and digital technologies relevant to the healthcare industry.

Professional Experience

Throughout his career, Brice has held various significant positions in reputable pharmaceutical companies:

• AstraZeneca: Current role as Key Account Manager in Haematology, focusing on Chronic Lymphocytic Leukemia (CLL)1
• Amicus Therapeutics
• PTC Therapeutics, Inc.
• Gilead Sciences

His experience spans multiple therapeutic areas, including:

• Hematology
• Rare diseases
• Multiple sclerosis
• Cardiology
• Infectiology
• Dermatology

Skills and Expertise

Brice de Kinkelin has demonstrated proficiency in:

• Pharmaceutical sales and marketing
• Strategic intelligence
• Market research and analysis
• Key account management
• Therapeutic specialization

His diverse background, which includes a stint as a Ski Instructor, showcases his adaptability and well-rounded professional experience.

Brice's LinkedIn profile (username: brice-de-kinkelin-98264026) reflects his extensive network, with over 500 connections in the industry.1 His current role at AstraZeneca allows him to leverage his expertise in marketing, strategic intelligence, and sales across various therapeutic areas, particularly in the field of hematology and chronic lymphocytic leukemia.2